Advertisement
Home »

Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review.

Mar 11, 2024

ABOUT THE EXPERTS

  • Fatima AlKindi

    Department of Internal Medicine, Tawam Hospital, Al Ain, ARE.

    Yousef Boobes

    Seha Kidney Care, Tawam Hospital, Al Ain, ARE.

    Department of Internal Medicine, College of Medicine and Health Sciences, Al Ain, ARE.

    Fatima Shalwani

    Department of Internal Medicine, Tawam Hospital, Al Ain, ARE.

    Jawaher Ansari

    Department of Oncology, Tawam Hospital, Al Ain, ARE.

    Department of Internal Medicine, College of Medicine and Health Sciences, Al Ain, ARE.

    Raya Almazrouei

    Division of Endocrinology, Tawam Hospital, Al Ain, ARE.

    Department of Internal Medicine, College of Medicine and Health Sciences, Al Ain, ARE.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement